TMDX
TMDX
US89377M1099
TransMedics Group, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 605.494.000 441.540.000
37.1%
Cost of Revenue 242.688.000 179.459.000
35.2%
Gross Profit 362.806.000 262.081.000
38.4%
254.223.000 224.585.000
13.2%
Operating Income 108.583.000 37.496.000
189.6%
Pretax Income 107.522.000 35.780.000
200.5%
Net Income Common Stockholders 190.291.000 35.464.000
436.6%
-- --
--
-- --
--
ende